Overview of CAR-T Cell Therapy for Cancer Treatment

A cutting-edge immunotherapy technique called CAR-T cell Therapy Treatment is intended to cure a variety of malignancies, including blood diseases like leukemia and lymphoma. Through genetic modification, a patient's T cells are better able to identify and combat cancer cells.

Patients with relapsed or refractory tumors—especially B-cell cancers like lymphoma, leukemia, and multiple myeloma—who have not responded to standard treatments like chemotherapy or radiation are typically candidates for CAR-T therapy. Leukapheresis, in which T cells are isolated from the patient's blood via apheresis, is the first step in the procedure. Usually, this process takes two to four hours.